ARCHIVES

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 07 No. 09 | February 27, 1981

Download PDF Visit The Full Archive

Related Articles

News Analysis: IOM Report A Case Study In Communications Disaster

February 5, 1999

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

Jury Awards $14 Million To Medenica Patient

February 24, 1995

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996